Hepatocyte growth factor/scatter factor (HGF/SF) and its cell-surface receptor, the tyrosine kinase c-Met, were found to be closely linked with glioma cell invasion and tumor progression (124), and c-Met has been widely confirmed as a crucial predictor of GBM patient outcomes (125). The gene discussed is MET; the disease is central nervous system cancer.